Allspring Global Investments Holdings LLC Buys 183,040 Shares of Azenta, Inc. (NASDAQ:AZTA)

Allspring Global Investments Holdings LLC grew its position in Azenta, Inc. (NASDAQ:AZTA) by 16.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,298,856 shares of the company’s stock after acquiring an additional 183,040 shares during the period. Allspring Global Investments Holdings LLC owned 2.41% of Azenta worth $62,917,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of AZTA. Hantz Financial Services Inc. bought a new position in Azenta in the second quarter valued at about $30,000. Benjamin F. Edwards & Company Inc. acquired a new stake in Azenta in the first quarter valued at $38,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Azenta in the first quarter valued at $49,000. Lazard Asset Management LLC bought a new position in Azenta during the 1st quarter worth $130,000. Finally, Acadian Asset Management LLC lifted its holdings in Azenta by 24.7% during the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock worth $143,000 after buying an additional 471 shares during the period. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

AZTA has been the subject of several recent research reports. Evercore ISI decreased their price target on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC restated a “buy” rating and issued a $69.00 price target on shares of Azenta in a research report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Azenta presently has an average rating of “Hold” and a consensus price target of $66.40.

Azenta Stock Down 0.9 %

NASDAQ:AZTA opened at $43.74 on Tuesday. Azenta, Inc. has a twelve month low of $43.18 and a twelve month high of $69.16. The company has a fifty day moving average of $48.10 and a 200-day moving average of $51.88. The firm has a market capitalization of $2.36 billion, a P/E ratio of -16.14 and a beta of 1.47.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.09. The firm had revenue of $173.00 million during the quarter, compared to the consensus estimate of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The business’s revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.13 earnings per share. On average, analysts anticipate that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

Insider Buying and Selling

In other Azenta news, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total value of $69,669.60. Following the completion of the sale, the chief financial officer now owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.77% of the stock is owned by company insiders.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.